Treatment Of Acute Gastroenteritis In Children: An Overview Of Systematic Reviews Of Interventions Commonly Used In Developed Countries

Evidence-Based Child Health

Volumn 8, Issue 4, 2013, Pages 1123-1137

  Freedman, Stephen B ^a   Ali, Samina ^b   Oleszczuk, Marta ^b,c   Gouin, Serge ^d   Hartling, Lisa ^b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Anti emetics; Dehydration; Diarrhoea; Gastroenteritis; Probiotics; Rehydration; Vomiting

Indexed keywords

COTRIMOXAZOLE; DEXAMETHASONE; DIMENHYDRINATE; METOCLOPRAMIDE; ONDANSETRON; PLACEBO; PROBIOTIC AGENT;

ABDOMINAL DISTENSION; ABSENCE OF SIDE EFFECTS; ACUTE GASTROENTERITIS; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; DEHYDRATION; DEVELOPED COUNTRY; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; EMERGENCY WARD; HOSPITAL ADMISSION; HUMAN; INFECTIOUS DIARRHEA; LENGTH OF STAY; META ANALYSIS (TOPIC); ORAL REHYDRATION THERAPY; OUTCOME ASSESSMENT; PARALYTIC ILEUS; PERIORBITAL EDEMA; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEDATION; SEIZURE; SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); VOMITING;

ANTI-EMETICS; DEHYDRATION; DIARRHOEA; GASTROENTERITIS; PROBIOTICS; REHYDRATION; VOMITING;

ACUTE DISEASE; ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADOLESCENT; ANTIEMETICS; CHILD; CHILD, PRESCHOOL; DEVELOPED COUNTRIES; FEMALE; FLUID THERAPY; GASTROENTERITIS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; ONDANSETRON; PROBIOTICS; TREATMENT OUTCOME;

EID: 84880380230     PISSN: None     EISSN: 15576272     Source Type: Journal    
DOI: 10.1002/ebch.1932     Document Type: Article

References (44)

1. Payne DC, Vinje J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013; 368: 1121-1130.
2. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379: 2151-2161.
3. Freedman SB, Steiner MJ, Chan KJ. Oral ondansetron administration in emergency departments to children with gastroenteritis: an economic analysis. PLoS Med 2010; 7.
4. Malek MA, Curns AT, Holman RC, Fischer TK, Bresee JS, Glass RI, et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5years of age: United States, 1997 and 2000. Pediatrics 2006; 117: 1887-1892.
5. Majowicz SE, McNab WB, Sockett P, Henson S, Dore K, Edge VL, et al. Burden and cost of gastroenteritis in a Canadian community. J Food Prot 2006; 69: 651-659.
6. Dennehy PH. Acute diarrheal disease in children: Epidemiology, prevention, and treatment. Infect Dis Clin North Am 2005; 19: 585.
7. Powell EC, Hampers LC. Physician variation in test ordering in the management of gastroenteritis in children. Arch Pediatr Adolesc Med 2003; 157: 978-983.
8. Freedman SB, Gouin S, Bhatt M, Black KJL, Johnson D, Guimont C, et al. Prospective assessment of practice pattern variations in the treatment of pediatric gastroenteritis. Pediatrics 2011; 127: E287-E295.
9. Freedman SB, Sivabalasundaram V, Bohn V, Powell EC, Johnson DW, Boutis K. The treatment of pediatric gastroenteritis: a comparative analysis of pediatric emergency physicians' practice patterns. Acad Emerg Med 2011; 18: 38-45. Epub December 25, 2010.
10. Kinlin LM, Bahm A, Guttmann A, Freedman SB. Department resources and strategies employed in the treatment of pediatric gastroenteritis. Acad Emerg Med 2013; 20(4): 361-366.
11. Leung A, Prince T, Canadian Paediatric Society, Nutrition and Gastroenterology Committee. Oral reahydration therapy and early refeeding in the management of childhood gastroenteritis. Paediatr Child Health 2006; 8: 527-531.
12. Centres for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance and nutritional therapy. MMWR 2003; 52(No. RR-16): 1-18.
13. Hartling L, Bellemare S, Wiebe N, Russell K, Klassen TP, Craig W. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev 2006; CD004390. Epub July 21, 2006.
14. Pfeil N, Uhlig U, Kostev K, Carius R, Schroder H, Kiess W, et al. Antiemetic medications in children with presumed infectious gastroenteritis--pharmacoepidemiology in Europe and Northern America. J Pediatr 2008; 153: 659-662, 662.e1-3. Epub October 3, 2008.
15. Gouin S, Vo TT, Roy M, Lebel D, Gravel J. Oral dimenhydrinate versus placebo in children with gastroenteritis: a randomized controlled trial. Pediatrics 2012; 129: 1050-1055.
16. Uhlig U, Pfeil N, Gelbrich G, Spranger C, Syrbe S, Huegle B, et al. Dimenhydrinate in children with infectious gastroenteritis: a prospective RCT. Pediatrics 2009; 124: e622-e632. Epub September 16, 2009.
17. Fedorowicz Z, Jagannath VA, Carter B. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev 2011; Issue 9. Art. No.: CD005506. DOI: 10.1002/14651858.CD005506.pub5.
18. DeCamp LR, Byerley JS, Doshi N, Steiner MJ. Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis. Arch Pediatr Adolesc Med 2008; 162: 858-865. Epub September 3, 2008.
19. Cheng A. Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children. Paediatr Child Health 2011; 16: 177-182. Epub March 3, 2012.
20. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003; 52: 1-16. Epub November 25, 2003.
21. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; Issue 11. Art. No.: CD003048. DOI: 10.1002/14651858.CD003048.pub3.
22. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) [computer program] Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. 2011.
23. Szajewska H, Skorka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther 2009; 30: 960-961.
24. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. [Review] [52 refs]. Aliment Pharmacol Ther 2007; 25: 871-881.
25. Szajewska H, Skorka A, Dylag M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.[Erratum appears in Aliment Pharmacol Ther. 2009 Apr; 29(7): 800]. Aliment Pharmacol Ther 2007; 25: 257-264.
26. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. [Review] [37 refs]. J Pediatr Gastroenterol Nutr 2001; 33(Suppl 2): S17-S25.
27. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002; 47: 2625-2634.
28. Salari P, Nikfar S, Abdollahi M. A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allergy Drug Targets 2012; 11: 3-14. Epub Februrary 9, 2012.
29. Chmielewska A, Ruszczynski M, Szajewska H. Lactobacillus reuteri strain ATCC 55730 for the treatment of acute infectious diarrhoea in children: a meta-analysis of randomized controlled trials. Pediatr Wspolcz 2008; 10: 32-36.
30. Mrukowicz JZ, Szajewska H. Efficacy of probiotics in the treatment and prevention of acute diarrhea - Systematic review. Pediatr Wspolcz 2002; 4: 71-77.
31. Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 2012; 12(4): 395-410.
32. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109: 678-684.
33. Jadad AR, Carroll D, Moore A, McQuay H. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996; 66(2-3): 239-246. Epub 1996/08/01.
34. Higgins JPT, Green S, Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions, Vol. xxi. Chichester, England; Hoboken, NJ: Wiley-Blackwell; 2008; 649.
35. Ramsook C, Sahagun-Carreon I, Kozinetz CA, Moro-Sutherland D. A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med 2002; 39: 397-403. Epub March 29, 2002.
36. FDA. FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran). Available at: http://www.fda.gov/Drugs/DrugSafety/ucm310190.htm [accessed on 6 June 2013].
37. Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol 2013; 47: 437-439 Epub February 22, 2013.
38. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005; 24: 278-280 Epub March 8, 2005.
39. Horwitch CA, Furseth HA, Larson AM, Jones TL, Olliffe JF, Spach DH. Lactobacillemia in three patients with AIDS. Clin Infect Dis 1995; 21: 1460-1462 Epub December 1, 1995.
40. Piescik-Lech M, Shamir R, Guarino A, Szajewska H. Review article: the management of acute gastroenteritis in children. Aliment Pharmacol Ther 2013; 37: 289-303 Epub November 30, 2012.
41. Johnston BC, Shamseer L, da Costa BR, Tsuyuki RT, Vohra S. Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics 2010; 126: e222-e231 Epub June 23, 2010.
42. Churgay CA, Aftab Z. Gastroenteritis in Children: Part II. Prevention and Management. Am Fam Physician 2012; 85: 1066-1070.
43. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004; 145: 612-616.
44. Tay K, Ewald MB, Bourgeois FT, eds. Use of the QTc prolonging drug ondansetron in children in US emergency departments. Boston, MA: Pediatric Academic Societies; 2012.